全文获取类型
收费全文 | 2028篇 |
免费 | 149篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 67篇 |
妇产科学 | 38篇 |
基础医学 | 201篇 |
口腔科学 | 33篇 |
临床医学 | 219篇 |
内科学 | 334篇 |
皮肤病学 | 30篇 |
神经病学 | 86篇 |
特种医学 | 185篇 |
外科学 | 147篇 |
综合类 | 239篇 |
一般理论 | 1篇 |
预防医学 | 178篇 |
眼科学 | 22篇 |
药学 | 245篇 |
中国医学 | 75篇 |
肿瘤学 | 103篇 |
出版年
2023年 | 11篇 |
2022年 | 12篇 |
2021年 | 36篇 |
2020年 | 38篇 |
2019年 | 23篇 |
2018年 | 36篇 |
2017年 | 40篇 |
2016年 | 35篇 |
2015年 | 45篇 |
2014年 | 78篇 |
2013年 | 94篇 |
2012年 | 124篇 |
2011年 | 139篇 |
2010年 | 102篇 |
2009年 | 100篇 |
2008年 | 138篇 |
2007年 | 124篇 |
2006年 | 76篇 |
2005年 | 89篇 |
2004年 | 60篇 |
2003年 | 63篇 |
2002年 | 55篇 |
2001年 | 51篇 |
2000年 | 41篇 |
1999年 | 33篇 |
1998年 | 30篇 |
1997年 | 27篇 |
1996年 | 31篇 |
1995年 | 20篇 |
1994年 | 15篇 |
1993年 | 16篇 |
1992年 | 17篇 |
1991年 | 34篇 |
1990年 | 30篇 |
1989年 | 37篇 |
1988年 | 24篇 |
1987年 | 27篇 |
1986年 | 23篇 |
1985年 | 20篇 |
1984年 | 33篇 |
1983年 | 40篇 |
1982年 | 20篇 |
1981年 | 25篇 |
1980年 | 20篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 14篇 |
1975年 | 12篇 |
1970年 | 8篇 |
1965年 | 6篇 |
排序方式: 共有2221条查询结果,搜索用时 46 毫秒
1.
H Meurs H F Kauffman A Timmermans F T van Amsterdam G H Ko?ter K de Vries 《Biochemical pharmacology》1986,35(23):4217-4222
Tumour-promoting phorbol esters such as phorbol 12-myristate 13-acetate (PMA) have been reported to modulate beta-adrenergic receptor responses in various cell types, presumably by the activation of protein kinase C. In the present investigation we assessed the effect of PMA on the beta-adrenergic receptor-adenylate cyclase system of human mononuclear leukocytes (MNL). It was found that incubation of MNL with PMA resulted in a time- and concentration-dependent desensitization of isoproterenol-induced adenylate cyclase activity. However, the effect of PMA was not restricted to the beta-adrenergic receptor system, since basal adenylate cyclase activity and histamine-, prostaglandin E1-, 5'-guanylylimidodiphosphate (GppNHp)-, and NaF-stimulated values were also reduced. By contrast, no effect was found on the forskolin-induced adenylate cyclase activity. The inactive phorbol ester, 4 alpha-phorbol 12,13-didecanoate had no effect on adenylate cyclase at all, suggesting that the observed PMA effect was specifically mediated by activation of protein kinase C. The reduced beta-adrenergic response induced by PMA was not associated with a reduced beta-adrenergic receptor number, indicating uncoupling of this receptor from adenylate cyclase. Isoproterenol competition curves for 3H-dihydroalprenolol binding to membranes from untreated and PMA-treated cells demonstrated that the uncoupling was due to a reduced ability of the agonist to promote formation of the guanine nucleotide-sensitive high affinity state of the receptor. The results indicate that PMA may cause desensitization of catecholamine-responsive adenylate cyclase in MNL, and that the major locus of alteration is the guanine nucleotide regulatory protein. 相似文献
2.
HA Carpay P Matthijsse M Steinbuch PGH Mulde 《Cephalalgia : an international journal of headache》1997,17(5):591-595
In an open, randomized cross-over study in 124 patients, we compared the efficacy, safety and patient preference of oral and subcutaneous sum triptan in the acute treatment of migraine. Patients were treated for 3 attacks or 3 months and then crossed over. Primary clinical efficacy was defined as a reduction in headache severity on a four-point self-rating scale from severe (3) or moderate (2) to mild (1) or none (0), or mild (1) to none (0). Efficacy was evaluated 2 h after the administration of subcutaneous and 4h after the administration of oral sumatriptan. Subcutaneous sumatriptan was significantly more effective than oral sumatriptan in relieving headache (over all three attacks 78% vs 61% improvement), improving clinical disability (55% vs 41 % improvement) and relieving nausea (69% vs 53%), vomiting (72% vs 32%) and phono- or photophobia (67% vs 49%). Median time to recurrence was shorter after subcutaneous (12.5 h) than after oral sumatriptan (18 h); the number of patients experiencing a recurrence was similar Patients reported more adverse events after subcutaneous sumatriptan (1.32 per attack) than after the oral form (0.85 per attack), but all adverse events were mild to moderate in intensity and of short duration. Patient opinion was more often positive after subcutaneous sumatriptan. These results may be useful in counselling patients to choose between the available marketed formulations of sumatriptan. 相似文献
3.
Boer K Nellen JF Patel D Timmermans S Tempelman C Wibaut M Sluman MA van der Ende ME Godfried MH 《BJOG : an international journal of obstetrics and gynaecology》2007,114(2):148-155
OBJECTIVE: To explore pregnancy outcome in HIV-1-positive and HIV-negative women, and mother-to-child transmission (MTCT) according to mode of delivery under effective highly active antiretroviral therapy (HAART). DESIGN: Cohort of 143 pregnant HIV-1-infected women including a matched case-control study in a 2:1 ratio of controls to cases (n=98). SETTING: Academic Medical Center in Amsterdam and Erasmus Medical Center in Rotterdam, the Netherlands. POPULATION: Consecutive referred HIV-1 infected pregnant women treated with HAART and matched control not infected pregnant women. MAIN OUTCOME MEASURES: MTCT, preterm delivery, low birthweight, pre-eclampsia. RESULTS: MTCT was 0% (95% CI 0-2.1%). Seventy-eight percent of HIV-1-infected women commenced and 62% completed vaginal delivery. The calculated number of caesarean sections needed to prevent a single MTCT was 131 or more. Preterm delivery rates were 18% (95% CI 11-27) in women infected with HIV-1 and 9% (95% CI 5-13) in controls (P=0.03). HAART used at <13 weeks of gestation was associated with a 44% preterm delivery rate compared with 21% when HAART was started at or after 13 weeks and 14% in controls. (Very) low birthweight and incidence of pre-eclampsia were not different between HIV-1 and controls. CONCLUSIONS: We have not demonstrated any MTCT after vaginal delivery in women effectively treated by HAART. The HAART-associated increase in preterm delivery rate is mainly seen after first trimester HAART use. 相似文献
4.
5.
6.
超细β-磷酸三钙/聚-L-乳酸复合材料的制备与骨折内固定器的加工 总被引:3,自引:0,他引:3
目的:制备分散性良好的超细β-磷酸三钙(β-TCP)/聚-L-乳酸(PLLA)复合材料及新型可吸收骨折内固定器。方法:通过研磨方法制备β-TCP超细粒子,用一缩二乙二醇作分散剂研磨β-TCP后,再将β-TCP与PLLA超声混合,制得复合材料,经注塑加工制成可吸收骨钉,并采用扫描电镜等方法进行表征。结果与结论:用一缩二乙二醇作分散剂研磨β-TCP后再经超声混合,可以使β-TCP超细粒子在复合材料中分散均匀,粒子大小仅为300nm左右,β-TCP与PLlA基体之间结合良好。超细β-TCP/PLLA复合材料可加工成可吸收骨钉,弯曲强度达到100MPa左右,完全满足松质骨内固定的要求。 相似文献
7.
MN Tabrizi† C Chams-Davatchi† N Esmaeeli† P Noormohammadpoor† F Safar† H Etemadzadeh† HA Ettehadi‡ F Gorouhi† 《Journal of the European Academy of Dermatology and Venereology》2007,21(1):79-84
BACKGROUND: Pemphigus vulgaris (PV) is a severe blistering disease involving the skin and mucous membranes. The most common causes of death in these patients are adverse effects of drugs, and infection. Skin lesions are one of the important sources of infection. Thus, any local treatment that could reduce healing time of lesions and consequently reduce the total dosage of drugs needed to treat is favourable. OBJECTIVE: To evaluate the efficacy of epidermal growth factor (EGF) in reducing healing time of lesions in patients with pemphigus vulgaris. METHODS: In this randomized, double-blind, within-patient, left/right, controlled trial, 20 hospitalized patients with pathologial and immunohistologial (direct and indirect immunoflourecence) proven pemphigus vulgaris (PV) were chosen. In addition, all patients had at least one appropriate pemphigus lesion on each side of the body that had not healed after 2-week systemic therapy and sterile saline washing. EGF (10 microg/g) in 0.1% silver sulfadiazine cream vs. 0.1% silver sulfadiazine cream alone was applied randomly on one side of the body. RESULTS: Kaplan-Meier survival analysis suggested that median time to heal with application of EGF plus silver sulfadiazine cream was 9 days, in comparison with 15 days for silver sulfadiazine cream alone (log-rank test, P=0.0003). No intervention-related adverse effect was observed during the study. CONCLUSIONS: EGF can significantly reduce healing time of skin lesions in patients with pemphigus vulgaris, at least when this cream base is applied (Cochrane skin group identifier: CSG20). 相似文献
8.
基于薄板样条和形状内容的医学图像非刚性配准方法研究 总被引:2,自引:0,他引:2
目的 针对医学图像非刚性点配准的现状,给出一种基于点特征的非刚性配准方法.方法 利用一种新的相似度测量方法--形状内容来解决两幅图像中点的对应关系,并利用点对应关系来估计非刚性映射函数.结果 利用薄板样条实现了医学图像的快速准确非刚性配准.结论 实验结果表明,上述方法获得了很好的配准效果. 相似文献
9.
10.